Home › ARCA Biopharma To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
 

Keywords :   


ARCA Biopharma To Present At The Rodman & Renshaw 17th Annual Global Investment Conference

2015-09-02 07:36:17| drugdiscoveryonline News Articles

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, recently announced that its Chief Operating Officer, Thomas A. Keuer, will present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place September 8-10, 2015 in New York City

Tags: present global annual conference

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Trump tariffs could cost UK 22bn of exports
08.11Watchdog to review police handling of Al Fayed abuse claims
08.11Cattle marketing: Its about making the right decisions
08.11Atlantic Tropical Weather Outlook
08.11Eastern North Pacific Tropical Weather Outlook
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Bolt drivers win right to holiday and minimum wage
08.11INX details acquisition, SpectraGraphics grows and more
More »